214 related articles for article (PubMed ID: 28940047)
1. Epidemiology of Cerebellar Diseases and Therapeutic Approaches.
Salman MS
Cerebellum; 2018 Feb; 17(1):4-11. PubMed ID: 28940047
[TBL] [Abstract][Full Text] [Related]
2. Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders.
Kalla R; Strupp M
Curr Neuropharmacol; 2019; 17(1):7-13. PubMed ID: 30182858
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar Ataxia in Children: A Clinical and MRI Approach to the Differential Diagnosis.
Alves CAPF; Fragoso DC; Gonçalves FG; Marussi VH; Amaral LLFD
Top Magn Reson Imaging; 2018 Aug; 27(4):275-302. PubMed ID: 30086112
[TBL] [Abstract][Full Text] [Related]
4. Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges.
Manto M; Cendelin J; Strupp M; Mitoma H
Expert Opin Ther Targets; 2023; 27(10):965-987. PubMed ID: 37768297
[TBL] [Abstract][Full Text] [Related]
5. [Genetic study of spinocerebellar hereditary degenerations in Tunisia. Role of consanguinity in their occurrence].
Ben Hamida M; Chaabouni H; Madani S; Boussen S; Samoud S; Letaief F; Mrabet A; Hentati F; Miladi N
J Genet Hum; 1986 Aug; 34(3-4):267-74. PubMed ID: 3760830
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive Cerebellar Stimulation in Cerebellar Disorders.
Di Nuzzo C; Ruggiero F; Cortese F; Cova I; Priori A; Ferrucci R
CNS Neurol Disord Drug Targets; 2018; 17(3):193-198. PubMed ID: 29623859
[TBL] [Abstract][Full Text] [Related]
7. Acute Ataxia in Childhood: 11-Year Experience at a Major Pediatric Neurology Referral Center.
Thakkar K; Maricich SM; Alper G
J Child Neurol; 2016 Aug; 31(9):1156-60. PubMed ID: 27071467
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of cerebellar disease.
Javalkar V; Khan M; Davis DE
Neurol Clin; 2014 Nov; 32(4):871-9. PubMed ID: 25439285
[TBL] [Abstract][Full Text] [Related]
9. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
10. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Ruano L; Melo C; Silva MC; Coutinho P
Neuroepidemiology; 2014; 42(3):174-83. PubMed ID: 24603320
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and afferent ataxias.
Pandolfo M; Manto M
Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1312-43. PubMed ID: 24092292
[TBL] [Abstract][Full Text] [Related]
12. Drug treatment.
Perlman S; Boltshauser E
Handb Clin Neurol; 2018; 155():371-377. PubMed ID: 29891072
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Zesiewicz TA; Wilmot G; Kuo SH; Perlman S; Greenstein PE; Ying SH; Ashizawa T; Subramony SH; Schmahmann JD; Figueroa KP; Mizusawa H; Schöls L; Shaw JD; Dubinsky RM; Armstrong MJ; Gronseth GS; Sullivan KL
Neurology; 2018 Mar; 90(10):464-471. PubMed ID: 29440566
[TBL] [Abstract][Full Text] [Related]
14. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.
Desai J; Mitchell WG
J Child Neurol; 2012 Nov; 27(11):1482-8. PubMed ID: 22805251
[TBL] [Abstract][Full Text] [Related]
15. Nonprogressive congenital ataxias.
Bertini E; Zanni G; Boltshauser E
Handb Clin Neurol; 2018; 155():91-103. PubMed ID: 29891079
[TBL] [Abstract][Full Text] [Related]
16. Autosomal recessive cerebellar ataxias.
Palau F; Espinós C
Orphanet J Rare Dis; 2006 Nov; 1():47. PubMed ID: 17112370
[TBL] [Abstract][Full Text] [Related]
17. Time Is Cerebellum.
Mitoma H; Manto M; Hampe CS
Cerebellum; 2018 Aug; 17(4):387-391. PubMed ID: 29460203
[TBL] [Abstract][Full Text] [Related]
18. Outcome of severe unilateral cerebellar hypoplasia.
Poretti A; Limperopoulos C; Roulet-Perez E; Wolf NI; Rauscher C; Prayer D; Müller A; Weissert M; Kotzaeridou U; Du Plessis AJ; Huisman TA; Boltshauser E
Dev Med Child Neurol; 2010 Aug; 52(8):718-24. PubMed ID: 19863638
[TBL] [Abstract][Full Text] [Related]
19. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
20. Task Force Paper On Cerebellar Transplantation: Are We Ready to Treat Cerebellar Disorders with Cell Therapy?
Cendelin J; Buffo A; Hirai H; Magrassi L; Mitoma H; Sherrard R; Vozeh F; Manto M
Cerebellum; 2019 Jun; 18(3):575-592. PubMed ID: 30607797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
